PNA Monomers

Fmoc-protected PNA monomers are the essential components for solid-phase synthesis of PNA oligomers. Designed with a base-labile Fmoc (9-fluorenylmethyloxycarbonyl) protecting group, these monomers are ideal for automated or manual synthesis using standard Fmoc chemistry.

PNA Bio Inc. offers Fmoc PNA monomers with >98% purity, ensuring reliable coupling efficiency and excellent solubility. Our monomers support high-yield synthesis of custom PNAs for research, diagnostics, and therapeutic development. Our Fmoc monomers provide the quality and consistency needed for successful PNA assembly.

Key Advantages

  • Ultra-high purity (>98%)
  • Excellent solubility
  • Reliable, high-efficiency conjugation performance
  • Competitive pricing

We also offer a wide selection of other PNA monomers such as Boc-protected PNA monomers (A, C, G, T, and U), as well as Fmoc-protected special monomers including J base and G clamp, in addition to gamma-PNA monomers (Lys, Glu, Ala, Ser, and Cys).

Fmoc PNA Monomers

High-quality PNA monomers for oligo synthesis – PNA Bio

Boc PNA Monomers

PNA monomers for peptide nucleic acid research – PNA Bio

Fmoc Gamma PNA Monomers

Fmoc Gamma PNA monomers

Cat No Item Description CAS Number Size
FMA-1001 Fmoc A monomer Fmoc-A(Bhoc)-aeg-OH 186046-82-2 2/5/10/25 grams
FMG-1001 Fmoc G monomer Fmoc-G(Bhoc)-aeg-OH 186046-83-3 2/5/10/25 grams
FMC-1001 Fmoc C monomer Fmoc-C(Bhoc)-aeg-OH 186046-81-1 2/5/10/25 grams
FMT-1001 Fmoc T monomer Fmoc-T-aeg-OH 169396-92-3 2/5/10/25 grams
FMO-1001 Fmoc AEEA linker Fmoc-AEEA-OH 166108-71-0 2/5/10/25 grams
BMA-1001 Boc A monomer Boc-PNA-A(Z)-OH 149376-69-2 1/2/5/10 grams
BMG-1001 Boc G monomer Boc-PNA-G(Z)-OH 169287-77-8 1/2/5/10 grams
BMC-1001 Boc C monomer Boc-PNA-C(Z)-OH 144564-94-3 1/2/5/10 grams
BMT-1001 Boc T monomer Boc-PNA-T-OH 139166-80-6 1/2/5/10 grams
BMU-1001 Boc U monomer Boc-PNA-U-OH 149500‑74‑3 1/2/5/10 grams

For inquiries or custom requests, please contact us at order@pnabio.com

  1. Enhancement of RNA Imaging Platforms by the Use of Peptide Nucleic Acid-Based Linkers. Wierzba AJ et al. (2026) Bio Protoc 16(12):e5453.
  2. Designing Programmable Peptide Nucleic Acid-based Nanovaccines for Anticancer Immune Activation. Huang Y et al. (2025) Small 21(51):e05605.
  3. Unveiling the promise of peptide nucleic acids as functional linkers for an RNA imaging platform. Wierzba AJ et al. (2025) RSC Chem Biol 6:249–262.
  4. Peptide Nucleic Acid-Mediated Regulation of CRISPR-Cas9 Specificity. Carufe KEW et al. (2024) Nucleic Acid Ther 34(5):245–256.
  5. Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting. Westerlund K et al. (2024) ACS Pharmacol Transl Sci 7(5):1595–1611.
  6. Targeting a KRAS i-motif forming sequence by unmodified and gamma-modified peptide nucleic acid oligomers. Sarkar S et al. (2023) Biopolymers 114(1):e23529.
  7. Antispacer peptide nucleic acids for sequence-specific CRISPR-Cas9 modulation. Economos NG et al. (2022) Nucleic Acids Res 50(10):e59.
  8. Machine Learning Guides Peptide Nucleic Acid Flow Synthesis and Sequence Design. Li C et al. (2022) Adv Sci 9(34):e2201988.
  9. Automated Flow Synthesis of Peptide–PNA Conjugates. Li C et al. (2022) ACS Cent Sci 8(2):205–213.
  10. Efficient antisense inhibition reveals microRNA-155 to restrain a late-myeloid inflammatory programme in primary human phagocytes. Linden G et al. (2021) RNA Biol 18(5):604–618.
  11. Role of nanoscale antigen organization on B-cell activation probed using DNA origami. Veneziano R et al. (2020) Nat Nanotechnol 15(8):716–723.
  12. Synthetic molecular evolution of hybrid cell penetrating peptides. Kauffman WB et al. (2018) Nat Commun 9:2568.
  13. Poly(oligonucleotide). James CR et al. (2014) J Am Chem Soc 136(32):11216–11219.

Please email a quotation request or questions to order@pnabio.com.